Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 2,569-2,580 of 4,306
Other study type icon
Active Not RecruitingNCT06539611

Prospective Cohort Study of a Population at Risk of Psychotic Transition

This summary needs review. Please check the official study record and contact the research team for details.

In Limoges
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaObservationalA study where researchers collect information without assigning a treatment.From 15 Years to 30 Years
Countries
France
Sponsor
Centre Hospitalier Esquirol
Condition
Schizophrenia
Other study type icon
CompletedNCT00877552

Prospective Studies of the Pathogenesis of Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Chapel Hill
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaObservationalUp to 6 Years
Countries
United States
Sponsor
University of North Carolina, Chapel Hill
Condition
Schizophrenia
Behavioral study icon
CompletedNCT04280835

Psychoeducation in Patients Who Diagnosed With Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Ankara
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 18 Years to 61 Years
Countries
Türkiye
Sponsor
Gazi University
Condition
Schizophrenia
Drug study icon
WithdrawnNCT01908452

Pyridoxal Kinase Activity in Tardive Dyskinesia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Beersheba
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
Israel
Sponsor
Beersheva Mental Health Center
Condition
Schizophrenia
Drug study icon
TerminatedNCT00498004

Quality of Life (QOL) in Female Patient With Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Busan
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 60 Years
Countries
South Korea
Sponsor
Inje University
Condition
Schizophrenia
Drug study icon
CompletedNCT02109562

Safety study of Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in schizophrenia

This study is completed in the United States. It is testing Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 for schizophrenia.

Multiple locations, including Little Rock
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
Indivior Inc.
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.